Pandox AB Series B
Pandox AB (publ), a hotel property company, owns, develops, and leases hotel properties. The company operates in two segments, Leases and Own Operations. The Leases segment leases hotels to hotel operators. The Own Operations segment owns hotel properties; and operates hotels. It has operations in Sweden, Denmark, Norway, Finland, Germany, Belgium, the United Kingdom, Ireland, and internationally… Read more
Pandox AB Series B (0R8U) - Total Liabilities
Latest total liabilities as of September 2021: Skr40.85 Billion SEK
Based on the latest financial reports, Pandox AB Series B (0R8U) has total liabilities worth Skr40.85 Billion SEK as of September 2021.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Pandox AB Series B - Total Liabilities Trend (2016–2020)
This chart illustrates how Pandox AB Series B's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Pandox AB Series B Competitors by Total Liabilities
The table below lists competitors of Pandox AB Series B ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Healthcare Services Group Inc
NASDAQ:HCSG
|
USA | $180.03 Million |
|
Technogym SpA
LSE:0RG1
|
UK | €410.90 Million |
|
Qi An Xin Technology Group Inc
SHG:688561
|
China | CN¥6.56 Billion |
|
Shenzhen Jufei Optoelectronics
SHE:300303
|
China | CN¥2.53 Billion |
|
Innodata Inc
NASDAQ:INOD
|
USA | $55.68 Million |
|
Transportadora de Gas del Sur SA B
BA:TGSU2
|
Argentina | AR$1.32 Trillion |
|
SNGN Romgaz SA
LSE:SNGR
|
UK | $3.74 Billion |
Liability Composition Analysis (2016–2020)
This chart breaks down Pandox AB Series B's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.49 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.65 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.62 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Pandox AB Series B's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Pandox AB Series B (2016–2020)
The table below shows the annual total liabilities of Pandox AB Series B from 2016 to 2020.
| Year | Total Liabilities | Change |
|---|---|---|
| 2020-12-31 | Skr40.94 Billion | +3.73% |
| 2019-12-31 | Skr39.46 Billion | +17.32% |
| 2018-12-31 | Skr33.64 Billion | +2.27% |
| 2017-12-31 | Skr32.89 Billion | +40.88% |
| 2016-12-31 | Skr23.35 Billion | -- |